WIM

Woodford Investment Management Portfolio holdings

AUM $310M
1-Year Est. Return 17.41%
This Quarter Est. Return
1 Year Est. Return
-17.41%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$591M
AUM Growth
-$648M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
8
New
Increased
Reduced
Closed

Top Buys

1
+$14.5M

Top Sells

1
+$149M
2
+$96.3M
3
+$70.9M
4
PRTA icon
Prothena Corp
PRTA
+$33.3M
5
TBPH icon
Theravance Biopharma
TBPH
+$19.9M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TBPH icon
1
Theravance Biopharma
TBPH
$743M
$199M 33.59%
12,159,980
-1,219,999
AUTL
2
Autolus Therapeutics
AUTL
$375M
$187M 31.58%
11,594,234
-447,185
PRTA icon
3
Prothena Corp
PRTA
$552M
$92.7M 15.69%
8,773,790
-3,150,824
EVFM
4
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$91.2M 15.43%
915,589
+146,007
NCNA
5
NuCana
NCNA
$6.93M
$22M 3.72%
424
-222
AGIO icon
6
Agios Pharmaceuticals
AGIO
$2.33B
– –
-2,214,459
ALKS icon
7
Alkermes
ALKS
$5.02B
– –
-2,639,676
BIIB icon
8
Biogen
BIIB
$21.9B
– –
-300,040